Search

Pancham Bakshi

Examiner (ID: 4910)

Most Active Art Unit
1623
Art Unit(s)
1623, 1673, 1671, 1621
Total Applications
1480
Issued Applications
1026
Pending Applications
167
Abandoned Applications
342

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18186318 [patent_doc_number] => 11576876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Affinity Medicant Conjugate [patent_app_type] => utility [patent_app_number] => 17/347533 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 73 [patent_no_of_words] => 49308 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347533
Affinity Medicant Conjugate Jun 13, 2021 Issued
Array ( [id] => 19263493 [patent_doc_number] => 20240207190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY [patent_app_type] => utility [patent_app_number] => 18/001184 [patent_app_country] => US [patent_app_date] => 2021-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001184 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001184
FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY Jun 7, 2021 Pending
Array ( [id] => 18509993 [patent_doc_number] => 20230226088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => THERAPEUTICS FOR TREATMENT OF COVID-19 SYMPTOMS [patent_app_type] => utility [patent_app_number] => 18/009203 [patent_app_country] => US [patent_app_date] => 2021-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6875 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009203 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/009203
THERAPEUTICS FOR TREATMENT OF COVID-19 SYMPTOMS Jun 6, 2021 Pending
Array ( [id] => 18468785 [patent_doc_number] => 20230203067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => PRODUCTION PROCESS FOR AMINO ALCOHOLATES [patent_app_type] => utility [patent_app_number] => 17/998831 [patent_app_country] => US [patent_app_date] => 2021-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6576 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998831 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998831
PRODUCTION PROCESS FOR AMINO ALCOHOLATES Jun 3, 2021 Pending
Array ( [id] => 18994924 [patent_doc_number] => 11911744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Superabsorbent materials and methods of making the same [patent_app_type] => utility [patent_app_number] => 17/339416 [patent_app_country] => US [patent_app_date] => 2021-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 6 [patent_no_of_words] => 10229 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339416 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/339416
Superabsorbent materials and methods of making the same Jun 3, 2021 Issued
Array ( [id] => 20129211 [patent_doc_number] => 12371513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-29 [patent_title] => Post-crosslinking partial degradation of amide crosslinked hydrogels [patent_app_type] => utility [patent_app_number] => 17/334373 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11856 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334373 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/334373
Post-crosslinking partial degradation of amide crosslinked hydrogels May 27, 2021 Issued
Array ( [id] => 18522942 [patent_doc_number] => 20230233592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1 IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIES [patent_app_type] => utility [patent_app_number] => 17/999634 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5599 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999634 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999634
PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1 IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIES May 23, 2021 Pending
Array ( [id] => 17080566 [patent_doc_number] => 20210275572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => METHODS FOR REDUCING CHOLESTEROL WITH SUPERABSORBENT MATERIALS [patent_app_type] => utility [patent_app_number] => 17/327037 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/327037
Methods for reducing cholesterol with superabsorbent materials May 20, 2021 Issued
Array ( [id] => 17080565 [patent_doc_number] => 20210275571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => TREATMENT FOR OBESITY WITH SUPERABSORBENT MATERIALS [patent_app_type] => utility [patent_app_number] => 17/327020 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18908 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327020 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/327020
Treatment for obesity with superabsorbent materials May 20, 2021 Issued
Array ( [id] => 18348634 [patent_doc_number] => 20230136745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA [patent_app_type] => utility [patent_app_number] => 17/918391 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918391 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918391
AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA May 10, 2021 Pending
Array ( [id] => 18348634 [patent_doc_number] => 20230136745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA [patent_app_type] => utility [patent_app_number] => 17/918391 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918391 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918391
AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREATMENT OF THROMBOCYTOPENIA May 10, 2021 Pending
Array ( [id] => 17228589 [patent_doc_number] => 20210355145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => PROCESS FOR PRODUCING DIMETHYLCHLOROSILANE COMPOUND [patent_app_type] => utility [patent_app_number] => 17/307178 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4197 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307178 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/307178
PROCESS FOR PRODUCING DIMETHYLCHLOROSILANE COMPOUND May 3, 2021 Abandoned
Array ( [id] => 17274423 [patent_doc_number] => 20210380621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => METHOD OF MAKING COBALT COMPOUNDS FOR FEED SUPPLEMENTS [patent_app_type] => utility [patent_app_number] => 17/307095 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307095 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/307095
Method of making cobalt compounds for feed supplements May 3, 2021 Issued
Array ( [id] => 18497480 [patent_doc_number] => 20230220121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => USE OF ALKANOLAMINES FOR LIGNIN EXTRACTION IN THE PRETREATMENT OF BIOMASS [patent_app_type] => utility [patent_app_number] => 17/925266 [patent_app_country] => US [patent_app_date] => 2021-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9658 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925266 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/925266
USE OF ALKANOLAMINES FOR LIGNIN EXTRACTION IN THE PRETREATMENT OF BIOMASS Apr 28, 2021 Pending
Array ( [id] => 17020883 [patent_doc_number] => 20210244754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES [patent_app_type] => utility [patent_app_number] => 17/242822 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/242822
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial DNA depletion syndromes Apr 27, 2021 Issued
Array ( [id] => 17183794 [patent_doc_number] => 20210330679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => PLATINUM-ACRIDINE COMPOUNDS AND METHODS OF TREATING CANCERS [patent_app_type] => utility [patent_app_number] => 17/235382 [patent_app_country] => US [patent_app_date] => 2021-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235382 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/235382
Platinum-acridine compounds and methods of treating cancers Apr 19, 2021 Issued
Array ( [id] => 18488187 [patent_doc_number] => 20230215535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE [patent_app_type] => utility [patent_app_number] => 17/996457 [patent_app_country] => US [patent_app_date] => 2021-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996457 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996457
METHOD FOR PROVIDING A MEDICAMENT COMBINATION AND DATA CARRIER WITH SOFTWARE Apr 19, 2021 Pending
Array ( [id] => 18374361 [patent_doc_number] => 20230149440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID [patent_app_type] => utility [patent_app_number] => 17/918652 [patent_app_country] => US [patent_app_date] => 2021-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3763 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918652 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918652
OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID Apr 15, 2021 Pending
Array ( [id] => 17005366 [patent_doc_number] => 20210236527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/231367 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231367
IMMUNOMODULATORY OLIGOSACCHARIDES Apr 14, 2021 Abandoned
Array ( [id] => 18603372 [patent_doc_number] => 11744812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-05 [patent_title] => Methods of treatment [patent_app_type] => utility [patent_app_number] => 17/231716 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38979 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231716 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231716
Methods of treatment Apr 14, 2021 Issued
Menu